SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-090855
Filing Date
2023-04-04
Accepted
2023-04-04 16:09:01
Documents
13
Period of Report
2023-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d460062d8ka.htm   iXBRL 8-K/A 40305
2 EX-10.3 d460062dex103.htm EX-10.3 219417
  Complete submission text file 0001193125-23-090855.txt   437814

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20230329.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20230329_lab.xml EX-101.LAB 18685
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20230329_pre.xml EX-101.PRE 11696
7 EXTRACTED XBRL INSTANCE DOCUMENT d460062d8ka_htm.xml XML 4217
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39101 | Film No.: 23797417
SIC: 8090 Services-Misc Health & Allied Services, NEC